Development of Bispecific Antibody for Cancer Immunotherapy: Focus on T Cell Engaging Antibody-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Bispecific Antibody for Cancer Immunotherapy: Focus on T Cell Engaging Antibody

Published:2022 Issue:1 Volume:22 Page:
ISSN:1598-2629
Container-title:Immune Network
language:en
Short-container-title:Immune Netw

Author:

Moon Dain¹^ORCID,Tae Nara²^ORCID,Park Yunji³^ORCID,Lee Seung-Woo¹^ORCID,Kim Dae Hee⁴^ORCID

Affiliation:

1. Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, Korea.

2. Global/Gangwon Innovative Biologics Regional Leading Research Center (GIB-RLRC), Kangwon National University, Chuncheon 24341, Korea.

3. Pohang University of Science and Technology (POSTECH) Biotech Center, POSTECH, Pohang 37673, Korea.

4. College of Pharmacy, Kangwon National University, Chuncheon 24341, Korea.

Funder

Bio & Medical Technology Development Program

Regional Leading Research Center program

National Research Foundation of Korea

Publisher

The Korean Association of Immunobiologists

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

https://immunenetwork.org/pdf/10.4110/in.2022.22.e4

Reference129 articles.

1. Recombination of a mixture of univalent antibody fragments of different specificity

2. SEROLOGIC DEMONSTRATION OF DUAL SPECIFICITY OF RABBIT BIVALENT HYBRID ANTIBODY

3. Continuous cultures of fused cells secreting antibody of predefined specificity

4. Hybrid hybridomas and their use in immunohistochemistry

5. Advantages of bispecific hybridomas in one-step immunocytochemistry and immunoassays.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges;Molecular Biotechnology;2024-09-02

2. Bispecific T-Cell Engagers (BiTEs) in Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

3. Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines;Frontiers in Immunology;2024-08-14

4. Bispecific antibodies: advancing precision oncology;Trends in Cancer;2024-08

5. CAR-T-Cell-Based Cancer Immunotherapies: Potentials, Limitations, and Future Prospects;Journal of Clinical Medicine;2024-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3